Titre : Maladies de la moelle osseuse

Maladies de la moelle osseuse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Digestive System Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Maladies de la moelle osseuse : Questions médicales les plus fréquentes", "headline": "Maladies de la moelle osseuse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Maladies de la moelle osseuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-15", "dateModified": "2025-04-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Maladies de la moelle osseuse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hémopathies", "url": "https://questionsmedicales.fr/mesh/D006402", "about": { "@type": "MedicalCondition", "name": "Hémopathies", "code": { "@type": "MedicalCode", "code": "D006402", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aplasies médullaires", "alternateName": "Bone Marrow Failure Disorders", "url": "https://questionsmedicales.fr/mesh/D000080983", "about": { "@type": "MedicalCondition", "name": "Aplasies médullaires", "code": { "@type": "MedicalCode", "code": "D000080983", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.223" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie aplasique", "alternateName": "Anemia, Aplastic", "url": "https://questionsmedicales.fr/mesh/D000741", "about": { "@type": "MedicalCondition", "name": "Anémie aplasique", "code": { "@type": "MedicalCode", "code": "D000741", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.223.250" } } } ] }, { "@type": "MedicalWebPage", "name": "Maladies myélodysplasiques-myéloprolifératives", "alternateName": "Myelodysplastic-Myeloproliferative Diseases", "url": "https://questionsmedicales.fr/mesh/D054437", "about": { "@type": "MedicalCondition", "name": "Maladies myélodysplasiques-myéloprolifératives", "code": { "@type": "MedicalCode", "code": "D054437", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.615" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Leucémie myélomonocytaire juvénile", "alternateName": "Leukemia, Myelomonocytic, Juvenile", "url": "https://questionsmedicales.fr/mesh/D054429", "about": { "@type": "MedicalCondition", "name": "Leucémie myélomonocytaire juvénile", "code": { "@type": "MedicalCode", "code": "D054429", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.615.520" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndromes myélodysplasiques", "alternateName": "Myelodysplastic Syndromes", "url": "https://questionsmedicales.fr/mesh/D009190", "about": { "@type": "MedicalCondition", "name": "Syndromes myélodysplasiques", "code": { "@type": "MedicalCode", "code": "D009190", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie réfractaire", "alternateName": "Anemia, Refractory", "url": "https://questionsmedicales.fr/mesh/D000753", "about": { "@type": "MedicalCondition", "name": "Anémie réfractaire", "code": { "@type": "MedicalCode", "code": "D000753", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.062" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie réfractaire avec excès de blastes", "alternateName": "Anemia, Refractory, with Excess of Blasts", "url": "https://questionsmedicales.fr/mesh/D000754", "about": { "@type": "MedicalCondition", "name": "Anémie réfractaire avec excès de blastes", "code": { "@type": "MedicalCode", "code": "D000754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.062.080" } } } ] }, { "@type": "MedicalWebPage", "name": "Anémie réfractaire avec excès de blastes", "alternateName": "Anemia, Refractory, with Excess of Blasts", "url": "https://questionsmedicales.fr/mesh/D000754", "about": { "@type": "MedicalCondition", "name": "Anémie réfractaire avec excès de blastes", "code": { "@type": "MedicalCode", "code": "D000754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.062.080" } } }, { "@type": "MedicalWebPage", "name": "Anémie sidéroblastique", "alternateName": "Anemia, Sideroblastic", "url": "https://questionsmedicales.fr/mesh/D000756", "about": { "@type": "MedicalCondition", "name": "Anémie sidéroblastique", "code": { "@type": "MedicalCode", "code": "D000756", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.070" } } }, { "@type": "MedicalWebPage", "name": "Hémoglobinurie paroxystique", "alternateName": "Hemoglobinuria, Paroxysmal", "url": "https://questionsmedicales.fr/mesh/D006457", "about": { "@type": "MedicalCondition", "name": "Hémoglobinurie paroxystique", "code": { "@type": "MedicalCode", "code": "D006457", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.625.460" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndromes myéloprolifératifs", "alternateName": "Myeloproliferative Disorders", "url": "https://questionsmedicales.fr/mesh/D009196", "about": { "@type": "MedicalCondition", "name": "Syndromes myéloprolifératifs", "code": { "@type": "MedicalCode", "code": "D009196", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie myélophtisique", "alternateName": "Anemia, Myelophthisic", "url": "https://questionsmedicales.fr/mesh/D000750", "about": { "@type": "MedicalCondition", "name": "Anémie myélophtisique", "code": { "@type": "MedicalCode", "code": "D000750", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636.085" } } }, { "@type": "MedicalWebPage", "name": "Leucémie érythroblastique aigüe", "alternateName": "Leukemia, Erythroblastic, Acute", "url": "https://questionsmedicales.fr/mesh/D004915", "about": { "@type": "MedicalCondition", "name": "Leucémie érythroblastique aigüe", "code": { "@type": "MedicalCode", "code": "D004915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636.276" } } }, { "@type": "MedicalWebPage", "name": "Myélofibrose primitive", "alternateName": "Primary Myelofibrosis", "url": "https://questionsmedicales.fr/mesh/D055728", "about": { "@type": "MedicalCondition", "name": "Myélofibrose primitive", "code": { "@type": "MedicalCode", "code": "D055728", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636.765" } } }, { "@type": "MedicalWebPage", "name": "Thrombocytose", "alternateName": "Thrombocytosis", "url": "https://questionsmedicales.fr/mesh/D013922", "about": { "@type": "MedicalCondition", "name": "Thrombocytose", "code": { "@type": "MedicalCode", "code": "D013922", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378.190.636.860" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Maladies de la moelle osseuse", "alternateName": "Bone Marrow Diseases", "code": { "@type": "MedicalCode", "code": "D001855", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sebastian Berg", "url": "https://questionsmedicales.fr/author/Sebastian%20Berg", "affiliation": { "@type": "Organization", "name": "Division of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany." } }, { "@type": "Person", "name": "Charlotte Niemeyer", "url": "https://questionsmedicales.fr/author/Charlotte%20Niemeyer", "affiliation": { "@type": "Organization", "name": "Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany." } }, { "@type": "Person", "name": "Ioannis Mitroulis", "url": "https://questionsmedicales.fr/author/Ioannis%20Mitroulis", "affiliation": { "@type": "Organization", "name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)." } }, { "@type": "Person", "name": "George Hajishengallis", "url": "https://questionsmedicales.fr/author/George%20Hajishengallis", "affiliation": { "@type": "Organization", "name": "Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia (G.H.)." } }, { "@type": "Person", "name": "Triantafyllos Chavakis", "url": "https://questionsmedicales.fr/author/Triantafyllos%20Chavakis", "affiliation": { "@type": "Organization", "name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors.", "datePublished": "2023-06-09", "url": "https://questionsmedicales.fr/article/37373091", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24129945" } }, { "@type": "ScholarlyArticle", "name": "Investigating Causal Associations of Diet-Derived Circulating Antioxidants with the Risk of Digestive System Cancers: A Mendelian Randomization Study.", "datePublished": "2022-08-08", "url": "https://questionsmedicales.fr/article/35956413", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/nu14153237" } }, { "@type": "ScholarlyArticle", "name": "The Relationship Between Plant-Based Diet and Risk of Digestive System Cancers: A Meta-Analysis Based on 3,059,009 Subjects.", "datePublished": "2022-06-03", "url": "https://questionsmedicales.fr/article/35719615", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.892153" } }, { "@type": "ScholarlyArticle", "name": "Adverse events of immune checkpoint inhibitors for patients with digestive system cancers: A systematic review and meta-analysis.", "datePublished": "2022-10-21", "url": "https://questionsmedicales.fr/article/36341450", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1013186" } }, { "@type": "ScholarlyArticle", "name": "Plant-based dietary patterns and the risk of digestive system cancers in 3 large prospective cohort studies.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37101016", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10654-023-01007-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Hémopathies et maladies lymphatiques", "item": "https://questionsmedicales.fr/mesh/D006425" }, { "@type": "ListItem", "position": 3, "name": "Hémopathies", "item": "https://questionsmedicales.fr/mesh/D006402" }, { "@type": "ListItem", "position": 4, "name": "Maladies de la moelle osseuse", "item": "https://questionsmedicales.fr/mesh/D001855" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Maladies de la moelle osseuse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Maladies de la moelle osseuse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Maladies de la moelle osseuse", "description": "Comment diagnostiquer une maladie de la moelle osseuse ?\nQuels tests sont utilisés pour évaluer la moelle osseuse ?\nQuels signes indiquent une maladie de la moelle osseuse ?\nQuelle imagerie est utilisée pour la moelle osseuse ?\nLes tests sanguins peuvent-ils détecter des maladies de la moelle ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Digestive+System+Neoplasms&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Maladies de la moelle osseuse", "description": "Quels sont les symptômes courants des maladies de la moelle osseuse ?\nComment la moelle osseuse affecte-t-elle le système immunitaire ?\nLes maladies de la moelle osseuse causent-elles des saignements ?\nPeut-on avoir des douleurs osseuses avec ces maladies ?\nLes symptômes varient-ils selon le type de maladie ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Digestive+System+Neoplasms&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Maladies de la moelle osseuse", "description": "Peut-on prévenir les maladies de la moelle osseuse ?\nQuels facteurs de risque sont évitables ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe tabagisme influence-t-il les maladies de la moelle ?\nLes examens réguliers aident-ils à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Digestive+System+Neoplasms&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Maladies de la moelle osseuse", "description": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?\nLa greffe de moelle osseuse est-elle efficace ?\nQuels médicaments sont utilisés pour traiter ces maladies ?\nLa radiothérapie est-elle une option de traitement ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Digestive+System+Neoplasms&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Maladies de la moelle osseuse", "description": "Quelles complications peuvent survenir avec ces maladies ?\nLes maladies de la moelle osseuse augmentent-elles le risque de cancer ?\nComment les infections sont-elles liées à ces maladies ?\nLes saignements peuvent-ils être graves ?\nQuelles sont les conséquences d'une insuffisance médullaire ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Digestive+System+Neoplasms&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Maladies de la moelle osseuse", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de maladies de la moelle ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie peut-il affecter le risque ?\nLes infections virales sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Digestive+System+Neoplasms&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie de la moelle osseuse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des analyses sanguines, biopsies et examens d'imagerie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la moelle osseuse ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'aspiration de moelle osseuse et des tests génétiques." } }, { "@type": "Question", "name": "Quels signes indiquent une maladie de la moelle osseuse ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent fatigue, infections fréquentes et saignements anormaux." } }, { "@type": "Question", "name": "Quelle imagerie est utilisée pour la moelle osseuse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et la tomodensitométrie sont souvent utilisées pour visualiser la moelle." } }, { "@type": "Question", "name": "Les tests sanguins peuvent-ils détecter des maladies de la moelle ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent révéler des anomalies dans les cellules sanguines." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des maladies de la moelle osseuse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, fièvre, ecchymoses et douleurs osseuses." } }, { "@type": "Question", "name": "Comment la moelle osseuse affecte-t-elle le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une moelle osseuse malade peut réduire la production de globules blancs, affaiblissant l'immunité." } }, { "@type": "Question", "name": "Les maladies de la moelle osseuse causent-elles des saignements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des saignements excessifs en raison d'une faible production de plaquettes." } }, { "@type": "Question", "name": "Peut-on avoir des douleurs osseuses avec ces maladies ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs osseuses peuvent survenir en raison de l'infiltration de cellules anormales." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de maladie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de maladie de la moelle osseuse." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies de la moelle osseuse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies sont héréditaires, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Quels facteurs de risque sont évitables ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des produits chimiques toxiques peut réduire le risque." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé de la moelle osseuse et du sang." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les maladies de la moelle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque pour plusieurs maladies hématologiques." } }, { "@type": "Question", "name": "Les examens réguliers aident-ils à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent chimiothérapie, radiothérapie et greffe de moelle osseuse." } }, { "@type": "Question", "name": "La greffe de moelle osseuse est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être curative pour certaines maladies, mais comporte des risques." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour traiter ces maladies ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les agents immunosuppresseurs et les facteurs de croissance sont utilisés." } }, { "@type": "Question", "name": "La radiothérapie est-elle une option de traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la radiothérapie peut être utilisée pour traiter certaines formes de cancer de la moelle." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent adaptés en fonction du type et de la gravité de la maladie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces maladies ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent infections, saignements et insuffisance médullaire." } }, { "@type": "Question", "name": "Les maladies de la moelle osseuse augmentent-elles le risque de cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies de la moelle osseuse peuvent augmenter le risque de cancers secondaires." } }, { "@type": "Question", "name": "Comment les infections sont-elles liées à ces maladies ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une moelle osseuse défaillante peut entraîner une immunodéficience, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Les saignements peuvent-ils être graves ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des saignements graves peuvent survenir en raison d'une faible production de plaquettes." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une insuffisance médullaire ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'insuffisance médullaire peut entraîner une anémie sévère, des infections et des hémorragies." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition à des radiations, des produits chimiques et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de maladies de la moelle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout après 60 ans." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles de la moelle osseuse." } }, { "@type": "Question", "name": "Le mode de vie peut-il affecter le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections virales sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de maladies de la moelle." } } ] } ] }

Sources (10000 au total)

The Relationship Between Plant-Based Diet and Risk of Digestive System Cancers: A Meta-Analysis Based on 3,059,009 Subjects.

Diets containing red or processed meat are associated with a growing risk of digestive system cancers. Whether a plant-based diet is protective against cancer needs a high level of statistical evidenc... We performed a meta-analysis of five English databases, including PubMed, Medline, Embase, Web of Science databases, and Scopus, on October 24, 2021 to identify published papers. Cohort studies or cas... The same results were found in cohort (adjusted RR = 0.82, 95% CI: 0.78-0.86,... Plant-based diets were protective against cancers of the digestive system, with no significant differences between different types of cancer.... https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022322276, Identifier: CRD42022322276....

Adverse events of immune checkpoint inhibitors for patients with digestive system cancers: A systematic review and meta-analysis.

To study the incidence and distribution of adverse events in immune checkpoint inhibitors (ICI) for digestive system cancers and to provide a reference for the safe, rational, and effective use of imm... We searched for articles published in English between January 1, 2010, and May 18, 2022. All clinical trials of ICI-based therapies for digestive system cancers were investigated, including only rando... We searched 2048 records, of which 21 studies (7108 patients) were eligible for inclusion. The incidence of ICI trAEs of any grade was 82.7% (95% CI 73.9-90.0), and the incidence of grade 3 or higher ... Our meta-analysis summarizes AEs associated with ICI in digestive system cancers. The incidence, characteristics, and distribution of AEs vary by cancer type, combination therapy modality, and differe...

Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.

We aimed to determine the impact of fibroblast activation protein inhibitor (FAPI)-directed molecular imaging on staging and therapeutic management in patients affected with digestive system tumors wh... Thirty-two patients with tumors of the digestive system were included: colon adenocarcinoma, 2/32 (6.3%); hepatocellular carcinoma (HCC), 6/32 (18.8%); pancreatic duct adenocarcinoma (PDAC), 6/32 (18.... Compared with GCI, 68 Ga-FAPI-04 PET/CT led to staging changes in 15/32 patients (46.9%). Among those, downstaging was recorded in 3/15 cases (20.0%) and upstaging in the remaining 12/15 patients (HCC... In patients affected with digestive system tumors, 68 Ga-FAPI-04 PET/CT resulted in staging changes in more than 46% and therapeutic modifications in 25% of the cases, in particular in patients with H...

Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.

Panel gene sequencing is an established diagnostic tool for precision oncology of solid tumors, but its utility for the treatment of cancers of the digestive system in clinical routine is less well do... We retrospectively identified patients with advanced or metastatic gastrointestinal, pancreaticobiliary or hepatic cancers who received panel gene sequencing at a tertiary university hospital from 201... In total, 155 patients received panel gene sequencing using either the Oncomine Focus (62 cases), Comprehensive (91 cases) or Childhood Cancer Research Assay (2 cases). The mean age of patients was 61... Actionable genetic alterations are frequently detected by panel gene sequencing in patients with advanced cancers of the digestive tract, providing clinical benefit in selected cases. However, for the...

The short- and long-term readmission of four major categories of digestive system cancers: does obesity or metabolic disorder matter?

Patients with digestive system cancers (DSCs) are at a high risk for hospitalizations; however, the risk factors for readmission remain unknown. Here, we established a retrospective cohort study to as... A total of 142,753 and 74,566 patients at index hospitalization were ultimately selected from the Nationwide Readmissions Database (NRD) 2018 to establish the 30-day and 180-day readmission cohorts, r... The MUNO phenotype had 1.147-fold (95% CI: 1.066, 1.235;... Both obesity and metabolic abnormalities are associated with a high risk for the poor prognosis of DSC patients. The effect of metabolic categories on the short- or long-term readmission of liver or p...

Effects of exercise by type and duration on quality of life in patients with digestive system cancers: A systematic review and network meta-analysis.

There is scant evidence regarding the effects of exercise type and duration on quality of life (QoL) in digestive system cancer (DSC) survivors. We aim to investigate the optimal type and duration of ... A systematic literature search of PubMed, Embase, and Web of Science was performed. Eligibility for study inclusion was limited to studies that were randomized controlled trials involving all kinds of... The analysis included 32 eligible articles and a total of 2558 participants. Our primary outcome indicated that short-term aerobic exercise significantly enhanced general health (standardized mean dif... This study suggests that short-term aerobic exercise, with or without resistance exercise programs, enhances QoL (especially for general health) as well as relieves cancer-related symptoms for DSC sur...

Deciphering the lipid-cancer nexus: comprehensive Mendelian randomization analysis of the associations between lipid profiles and digestive system cancer susceptibility.

Digestive system cancers represent a significant global health challenge and are attributed to a combination of demographic and lifestyle changes. Lipidomics has emerged as a pivotal area in cancer re... Using a two-sample Mendelian randomization (MR) approach, we elucidated the causal relationships between lipidomic profiles and the risk of five types of digestive system cancer: stomach, liver, esoph... Significant causal relationships were identified between certain lipidomic traits and the risk of developing digestive system cancers. Elevated sphingomyelin (d40:1) levels were associated with a redu... Our findings underscore the significant causal relationships between specific lipidomic traits and the risk of developing various digestive system cancers, highlighting the potential of lipid profiles...